John Newton

• Representing Partners Group on:
• its investment in Akur8, a machine learning-powered insurance pricing and reserving platform
• its acquisition of a majority stake in FairJourney Biologics from GHO Capital Partners
• the agreement to invest in Exus, a leading European infrastructure asset management firm focused on the renewable energy sector. Partners Group plans to commit up to EUR 1 billion in growth capital
• its investment in Sterling Pharma Solutions, a global CDMO, and co-shareholder arrangements with GHO Capital
• the €1.6 billion acquisition of Pharmathen, a European pharmaceutical company, from BC Partners
• the acquisition of Rovensa, a leading Portuguese-headquartered agricultural products business, and joint venture arrangements with Bridgepoint
• multiple co-investment and secondaries transactions
• Advised Bain Capital on:
  • its sale of the Zellis group to Apax Partners, valuing Zellis at £1.25 billion
  • the sale of a stake in Beat Capital Partners to Ambac Financial Group
  • its acquisition of NGA UK, a UK payroll and HR Business from NGA Human Resources
• Representing TPG on:
  • TPG’s Rise Fund
    • the acquisition of a majority investment in Outcomes First Group, a UK-based education business
  • TPG Capital
    • the sale of its joint venture stake in Denmark’s Saxo Bank to Geely, a Chinese corporate, and Sampo, a Finnish insurance company
    • the acquisition of PhysIOL Group SA, a Belgian medical devices company, by its portfolio company BVI Medical
    • the acquisition of Malosa Medical, a UK-based medical devices company, by its portfolio company BVI Medical
    • the acquisition of Vitreq, acquisition of Vitreq, a Netherlands-based medical devices company, by its portfolio company BVI Medical
    • the acquisition of a majority stake in Poundworld
    • the sale of WellSky International by its portfolio company WellSky Corporation
    • the acquisition of FilmTech startup, We Got POP, by its portfolio company Entertainment Partners
  • TPG Growth
    • its investment into Musixmatch, a leading global music data platform
    • the acquisition of Goal (FootballCo) from the DAZN Group by TPG digital media platform Integrated Media Company
    • the acquisition of Kooora by its portfolio company FootballCo
• Representing GHO Capital Partners on the acquisition of Envision Pharma Group, a pharmaceutical services company
• Representing 3i Group plc:
• on its investment in Digital Barriers, a leading provider of digital surveillance and security products
• on the acquisition of Audley Travel, a provider of tailor-made experiential holidays
• on its investment in MPM, an international leader in branded, premium, natural pet food
• Representing ERM, the world’s largest sustainability consultancy, and the ERM Partner shareholders, on the $2.7billion sale of ERM to KKR
• Representing Nordic Capital:
• on equity investment and joint venture arrangements relating to the acquisition of ERT, a leading data and technology company in the clinical trials sector
• raising LP co-investment on multiple acquisitions, including Alloheim and Trustly
• Representing Genstar Capital and on the acquisition of CRF Health, a leading provider of eCOA solutions for the life sciences industry, by its portfolio company Bracket
• Representing Duke Street Capital on its acquisition of Great Rail Journeys, the world’s leading provider of escorted rail holidays
• Representing Silverfleet Capital on the acquisition of Riviera Travel, a leading specialist holiday operator
• Representing Summit Partners:
• on the sale of Actix International Limited to Amdocs Limited
• the joint venture with FleetCor to acquire UK-based Masternaut

Life Sciences M&A

• Advised NeoGenomics, Inc. on its acquisition of Inivata Ltd, a global, commercial stage liquid biopsy platform company, headquartered in Cambridge, UK
• Advised NeoGenomics Inc. in a strategic collaboration with Inivata for the commercialization of a liquid biopsy test in the United States

Co-investments

• Represented a range of PE funds, including Partners Group, Ardian, Crescent Capital and EBRD, on multiple co-investment transactions